Servier BioInnovation
$83.4M 11 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Incyte Corporation
Incyte Corporation reported $84,406,436.77 across General Payments, Research, and Ownership to 77,737 physicians and teaching hospitals across 109,620 transactions.
- $84.4M Top 10% payer
- All-tracks total
- 109,620 Top 10% volume
- Transactions
- 77,737 Top 10% reach
- Recipients
- −$1.4M
- General Payments vs PY2023
Incyte Corporation reported $84,406,436.77 across all CMS Open Payments tracks (General + Research + Ownership) to 77,737 physicians and teaching hospitals in Program Year 2024 - ranking #34 of 1,925 reporting manufacturers (0.6% of the all-tracks industry total); General Payments alone were $13,103,674.30, averaging $1.1K per recipient.
How Incyte Corporation's $84.4M all-tracks total breaks down
Incyte Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
100/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer incyte-corporation Incyte Corporation
$84.4M · #34/1,925 · 0.6% industry · PY2024
- TOT $84.4M
- RANK #34
- SHARE 0.6%
- TXN 109,620
- RCP 77,737
- CAT 10
- GEN $13.1M
- ΔGEN −$1.4M
- TOP1 12.8%
- PY 2024
Volume peers
Nearest volume peer: Servier BioInnovation ($83.4M)
Incyte Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Incyte Corporation's CMS-reported General Payments decreased by $1.4M (−9.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: INCYTE CORPORATIONPY2023: INCYTE CORPORATIONPY2024: Incyte Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $14,516,991.22
- PY2024
- $13,103,674.30
What the Data Shows for Incyte Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Incyte Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
1,983 transactions worth $4.9M make "Compensation for Services Other Than Consulting" the top general-payment category in the 10-category breakdown below, 37.0% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Incyte Corporation's 10-category general-payment breakdown at $4.9M, 37.0% of the reported total.
Incyte Corporation reports 10 general-payment categories - the top three are Compensation for Services Other Than Consulting (37.0%), Consulting Fee (19.8%), and Acquisitions (17.0%). The remaining 7 categories make up 26.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Incyte Corporation files across 10 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Incyte Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $4.9M | 1,983 | 37.0% |
| Consulting Fee | $2.6M | 622 | 19.8% |
| Acquisitions | $2.2M | 4 | 17.0% |
| Food and Beverage | $1.7M | 70,067 | 13.3% |
| Travel and Lodging | $862.5K | 3,139 | 6.6% |
| Space Rental or Facility Fees | $334.0K | 84 | 2.5% |
| Education | $305.4K | 1,831 | 2.3% |
| Grant | $145.0K | 3 | 1.1% |
| Royalty or License | $40.0K | 2 | 0.3% |
| Charitable Contribution | $6.4K | 2 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,874,596.74 (21.9%) of $13,103,674.30 in this company's General Payments records across 20,131 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Incyte Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Ethan Lerner
$1,678,253.33 across 1 reported transactions
- 2
Danielle Petersel
$460,463.06 across 1 reported transactions
- 3
Sandra Lee
$319,108.75 across 22 reported transactions
- 4
Serge Alexanian
$276,158.61 across 31 reported transactions
- 5
Ahmed Galal
$140,612.99 across 107 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Incyte Corporation ranks #34 of 1,925 by total payments (top 2% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,551 of 1,838 by HHI (bottom 16% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Mentor Worldwide LLC : $1.0M total payments, HHI 213
- Avation Medical, Inc. : $4.0K total payments, HHI 213
- US Oncology Corporate, Inc. : $55.9K total payments, HHI 209
- Southern Edge Orthopaedics, Inc. : $9.9K total payments, HHI 207
- Aurinia Pharma U.S., Inc. : $1.0M total payments, HHI 207
- Darby Dental Supply, LLC : $229.5K total payments, HHI 207
- Incyte Corporation (this company) : $13.1M total payments, HHI 206
- Mitsubishi Tanabe Pharma America, Inc. : $415.3K total payments, HHI 205
- Ferring Pharmaceuticals Inc. : $2.0M total payments, HHI 202
- Argentum Medical : $3.5K total payments, HHI 201
- Mission Medical Distribution, LLC : $32.7K total payments, HHI 201
- Painteq LLC : $367.8K total payments, HHI 201
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Incyte Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Incyte Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Incyte Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
CSL Behring
$88.2M 27,644 recipients
Compare payment profiles
Zimmer Biomet Holdings, Inc.
$88.6M 33,496 recipients
Compare payment profiles
Celgene Corporation
$88.9M 60,850 recipients
Compare payment profiles
BeiGene, Ltd.
$77.4M 57 recipients
Compare payment profiles
Abbott Laboratories
$91.7M 292,558 recipients
Compare payment profiles
Put this to use
Incyte Corporation ranks #34 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Incyte Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Incyte Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.